High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study

Huiling Zhu,Mengyao Zheng,Haiyu He,Hongtao Lei,Wenlin Tai,Jinhui Yang

BMC Gastroenterology（2023）

引用 0|浏览3

暂无评分

摘要

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts. Ursodeoxycholic acid (UDCA) is the only FDA approved first-line therapy for PBC, but up to 40

查看译文

关键词

Primary biliary cholangitis,Neutrophil-to-lymphocyte,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要